Key result
Pediatric balloon aortic valvuloplasty yields ~47% 10-year freedom from reintervention in long-term cohort.
Why the study?
The optimal initial treatment for critical aortic stenosis in children—balloon versus surgical aortic valvuloplasty—remains debated, motivating characterization of long-term outcomes with a first-line balloon approach.
Does balloon aortic valvuloplasty as first-line treatment provide long-term freedom from surgery and reintervention in neonates, infants, and children with critical congenital aortic stenosis?
Cohort (n=201)
No
Does balloon aortic valvuloplasty as first-line treatment provide long-term freedom from surgery and reintervention in neonates, infants, and children with critical congenital aortic stenosis?
Answers are grounded in this paper and cite their sources.
Balloon aortic valvuloplasty is an effective first-line treatment for infants and children with critical aortic stenosis, whereas nearly half of neonates require surgical intervention (most commonly a Ross procedure) at a median of 6 months.
Background: Initial treatment of critical aortic stenosis in children, balloon or surgical aortic valvuloplasty, remains debated. Our centre used the balloon procedure first in almost all patients for over 29 years, a predominantly balloon-first cohort. Objective: To characterise long-term outcomes of balloon aortic valvuloplasty as first-line treatment for critical aortic stenosis. Methods: We retrospectively reviewed 201 patients treated between June 1996 and December 2025, grouped as neonates (0–28 days), infants (29–365 days), and children (>365 days). Freedom from surgery and reintervention were analysed with the Kaplan–Meier method; categorical comparisons used chi-square tests. Results: Median follow-up was 9 years. Aortic valve surgery was required in 78 patients (38.8%), most commonly a Ross or Ross–Konno procedure (49, 62.8%). Neonates required surgery more often than infants and children (36/74, 48.6% versus 42/127, 33.1%; p = 0.042); median time to surgery in neonates was 6 months. One-year Kaplan–Meier freedom from surgery was 63% in neonates, 91% in infants, and 96% in children. Moderate-to-severe post-procedural valve dysfunction was associated with more surgery than mild dysfunction (49.3% versus 33.3%; p = 0.041). Kaplan–Meier freedom from any reintervention was 47% at 10 years and 31% at 15 years. Mortality was 3.5% overall and 8.1% in neonates, mostly in the early era. Conclusions: Balloon aortic valvuloplasty is an effective first-line treatment for infants and children with critical aortic stenosis. However, many neonates need surgery within the first year, usually a Ross procedure. In centres with experienced cardiac surgeons, surgical aortic valvuloplasty could be considered a reasonable alternative initial approach for neonates.
No takes yet. Share an insight, caveat, or question.
Özalp et al. (2026) conducted a cohort in Congenital aortic stenosis (n=201). Balloon aortic valvuloplasty (moderate-to-severe post-procedural valve dysfunction vs mild dysfunction) vs. Mild post-balloon aortic valvuloplasty valve dysfunction was evaluated on Subsequent valve surgery (p=0.041). Balloon aortic valvuloplasty in 201 children resulted in 47% freedom from reintervention at 10 years, with subsequent valve surgery occurring in 38.8% overall.
Synapse has enriched 10 related papers. Consider them for comparative context: